logo image
search icon
Global Peripheral Vascular Devices Market

Peripheral Vascular Devices Market Size, Share & Trends Analysis Report By Product Type (Aortic Stent Grafts, Arteriotomy Closure Devices, Carotid and Renal Artery Stents, Inferior Vena Cava Filters (IVCF)), By End-User, By Region, And By Segment Forecasts, 2024-2031

Report ID : 1054 | Published : 2024-03-28 | Pages: 190 | Format: PDF/EXCEL

The Peripheral Vascular Devices Market Size is valued at 10.46 Billion in 2023 and is predicted to reach 17.75 Billion by the year 2031 at a 6.87% CAGR during the forecast period for 2024-2031.

peripheral vascular devices

Peripheral vascular disease (PVD) is caused due to accumulation of plaque within the inside lining of arteries. With the increasing age, the incidence of PVD also increases. It is more common among the diabetic and smoking population. More than 5% of the population above age 50 years suffers from PVD. Insufficient blood flow and narrowing of arteries are the most common peripheral diseases caused due to plaque build-up. These diseases can be treated through minimally invasive surgeries. Peripheral vascular devices are used for the treatment of these blocked arteries and to remove the build-up plaque.

Peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, and aortic stents are the most used devices for the treatment of PVD. The growth of this market is driven by factors such as rising incidences of PVD, increasing demand for minimally invasive procedures, changing lifestyles, and the global aging population. Asia is expected to be the largest market with high growth opportunities owing to rising disposable income and the high unmet medical needs of the patient population.

Market Segmentation

The peripheral vascular devices market is a segment based on product type, end-user, and geography. In terms of product type, the global market is segregated aortic stent-grafts, arteriotomy closure devices, carotid and renal artery stents, inferior vena cava filters (IVCF), peripheral embolic protection devices, peripheral guidewires, peripheral vascular stents, PTA balloons catheters, PTA peripheral drug-eluting, balloons (DEB) catheters, renal denervation catheters, tip location devices, and vascular grafts. The peripheral vascular stents market holds a major share in the total peripheral vascular devices market.

The growth of this market is justified by the increasing incidence rate of lifestyle diseases such as obesity and diabetes. The embolic protection devices market is expected to grow at the highest growth rate during the forecasted period. Technological advancements in the devices such as tracking the position during the procedure and drug-coated stents would boost the demand for these devices as it overcomes the issues faced by surgeons.


Based on end-user, the global peripheral vascular devices market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. PVD is a vastly under-diagnosed disease, less than 30% of the total patient population are diagnosed with PVD. Lack of awareness among patients is the main reason for the under-diagnosis of PVD. It is estimated that 20% of the total patient population have PVD, and are prone to high-risk factors such as diabetes and obesity contributors for the development of PVD. Hence, with the increasing aging population, the incidence rate of PVD would also grow to impact the growth of the market. The rising incidence rate would have a high impact on the growth of the peripheral vascular devices market throughout the forecast period.


Based on geography, the global Peripheral Vascular Devices market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In terms of revenue, North America is estimated to account for the largest share in the global market in 2019. There is a general increase in the peripheral and lower limb procedures which would boost the market for these devices during the forecast period; more than 15% of the total aged population suffers from PAD in this region. The aging population in North America is expected to increase by around 5% every year.

However, the infections caused due to peripheral vascular implantations and surgeries would prove to be a challenge for the growth of these devices. In order to overcome these issues and meet patient's demands, manufacturers are coming up with newer and technologically advanced products which would increase the base of the treatable population. Market players such as Cordis Corporation, Boston Scientific Corporation, and Abbott Laboratories have a significant presence in the North American market.

Competitive Landscape

Some Major Key Players In The Peripheral Vascular Devices Market:

  • Abbott Laboratories,
  • Boston Scientific Corp,
  • Biotronik,
  • Bentley InnoMed GmbH,
  • Cardiva Medical Inc.,
  • Medtronic plc,
  • L. Gore & Associates Inc,
  • Avascular S.L.U,
  • Cook Medical Inc,
  • Terumo Corp,
  • Braun Melsungen AG,
  • Getinge AB,
  • R. Bard Inc (BD),
  • Cardinal Health Inc.,
  • Cordis Corp,
  • Endologix Inc,
  • Terumo Medical Corporation

Peripheral Vascular Devices Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 10.46 Billion

Revenue Forecast In 2031

USD 17.33 Billion

Growth Rate CAGR

CAGR of 6.8 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Billion, volume (units) and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product Type, By End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Abbott Laboratories, Boston Scientific Corp, Biotronik, Bentley InnoMed GmbH, Cardiva Medical Inc., Medtronic plc, W. L. Gore & Associates Inc, Avascular S.L.U, Cook Medical Inc, Terumo Corp, B. Braun Melsungen AG, Getinge AB, C. R. Bard Inc (BD), Cardinal Health Inc., Cordis Corp, Endologix Inc, and Terumo Medical Corporation among others.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Peripheral Vascular Devices Market Snapshot

Chapter 4. Global Peripheral Vascular Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis

5.1. by Product Type & Market Share, 2023 & 2031

5.2. Market Size (Value (US$ Mn) & Volume (no. of units) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:

5.2.1. Aortic Stent Grafts

5.2.2. Arteriotomy Closure Devices

5.2.3. Carotid and Renal Artery Stents

5.2.4. Inferior Vena Cava Filters (IVCF)

5.2.5. Peripheral Embolic Protection Devices

5.2.6. Peripheral Guidewires, Peripheral Vascular Stents

5.2.7. PTA Balloons Catheters

5.2.8. PTA Peripheral Drug Eluting

5.2.9. Balloons (DEB) Catheters

5.2.10. Renal Denervation Catheters

5.2.11. Tip Location Devices

5.2.12. Vascular Grafts

Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis

6.1. by End-users & Market Share, 2023 & 2031

6.2. Market Size (Value (US$ Mn) & Volume (no. of units) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-users:

6.2.1. Hospitals

6.2.2. Ambulatory Care Centers

6.2.3. Specialty Clinics

6.2.4. Others

Chapter 7. Peripheral Vascular Devices Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031

7.1.2. North America Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2024-2031

7.1.3. North America Peripheral Vascular Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

7.2. Europe

7.2.1. Europe Peripheral Vascular Devices Market revenue (US$ Million) by Product Type, 2024-2031

7.2.2. Europe Peripheral Vascular Devices Market revenue (US$ Million) by End-users, 2024-2031

7.2.3. Europe Peripheral Vascular Devices Market revenue (US$ Million) by country, 2024-2031

7.3. Asia Pacific

7.3.1. Asia Pacific Peripheral Vascular Devices Market revenue (US$ Million) by Product Type, 2024-2031

7.3.2. Asia Pacific Peripheral Vascular Devices Market revenue (US$ Million) by End-users, 2024-2031

7.3.3. Asia Pacific Peripheral Vascular Devices Market revenue (US$ Million) by country, 2024-2031

7.4. Latin America

7.4.1. Latin America Peripheral Vascular Devices Market revenue (US$ Million) by Product Type, 2024-2031

7.4.2. Latin America Peripheral Vascular Devices Market revenue (US$ Million) by End-users, 2024-2031

7.4.3. Latin America Peripheral Vascular Devices Market revenue (US$ Million) by country, 2024-2031

7.5. Middle East & Africa

7.5.1. Middle East & Africa Peripheral Vascular Devices Market revenue (US$ Million) by Product Type, 2024-2031

7.5.2. Middle East & Africa Peripheral Vascular Devices Market revenue (US$ Million) by End-users, 2024-2031

7.5.3. Middle East & Africa Peripheral Vascular Devices Market revenue (US$ Million) by country, 2024-2031

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Abbott Laboratories

8.2.2. Boston Scientific Corp

8.2.3. Biotronik

8.2.4. Bentley InnoMed GmbH

8.2.5. Cardiva Medical Inc.

8.2.6. Medtronic plc

8.2.7. W. L. Gore & Associates Inc

8.2.8. Avascular S.L.U

8.2.9. Cook Medical Inc

8.2.10. Terumo Corp

8.2.11. B. Braun Melsungen AG

8.2.12. Getinge AB

8.2.13. C. R. Bard Inc (BD)

8.2.14. Cardinal Health Inc.

8.2.15. Cordis Corp

8.2.16. Endologix Inc

8.2.17. Terumo Medical Corporation

8.2.18. Other Prominent Players

Global Peripheral Vascular Devices Market Segmentation

Global Peripheral Vascular Devices Market Outlook Value (US$ Mn) & Volume (No. of units), By Product Type

  • Aortic Stent Grafts 
  • Arteriotomy Closure Devices 
  • Carotid and Renal Artery Stents
  • Inferior Vena Cava Filters (IVCF)
  • Peripheral Embolic Protection Devices
  • Peripheral Guidewires, Peripheral Vascular Stents
  • PTA Balloons Catheters
  • PTA Peripheral Drug Eluting
  • Balloons (DEB) Catheters
  • Renal Denervation Catheters
  • Tip Location Devices
  • Vascular Grafts

peripheral vascular devices

Global Peripheral Vascular Devices Market Outlook Value (US$ Mn) & Volume (No. of units), By End-Users

  • Hospitals
    Ambulatory Care Centers
    Specialty Clinics
    Others

Global Peripheral Vascular Devices Market Outlook Value (US$ Mn) & Volume (No. of units), By Region

  • Europe
    • Germany
    • Poland
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

Who are the Key Players in the Global Peripheral Vascular Devices Market?

The Peripheral Vascular Devices Market Size is valued at 10.46 Billion in 2023 and is predicted to reach 17.75 Billion by the year 2031

The Peripheral Vascular Devices Market is expected to grow at a 6.87% CAGR during the forecast period for 2024-2031.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4500
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach